In March, 2021, a published study by Peter McCullough and 57 other front-line physicians from multiple countries found that “Our early ambulatory treatment regimen was associated with estimated 87.6 percent and 74.9 percent reductions in hospitalization and death.”19
Ivermectin is highly effective as a prophylactic or treatment of Covid.
